Literature DB >> 19487588

G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans.

Heather I Cohn1, Yihuan Xi, Stephanie Pesant, David M Harris, Terry Hyslop, Bonita Falkner, Andrea D Eckhart.   

Abstract

Hypertension occurs with higher prevalence and morbidity in black Americans compared with other groups. Alterations in the signal transduction pathways of 7-transmembrane spanning receptors are found in hypertensive patients. G protein-coupled receptor kinases (GRKs) play an important role in regulating this receptor signaling. The 2 most abundantly expressed GRKs in the cardiovascular system are GRK2 and GRK5, and each has unique substrates. Understanding changes in expression may give us insight into activated receptors in the pathophysiological progression of hypertension. In heart failure and white hypertensives, increased GRK2 expression arises because of neurohormonal stimulation of particular receptors. GRK2 subsequently desensitizes specific receptors, including beta-adrenergic receptors. In blood pressure control, beta-adrenergic receptor desensitization could lead to increased blood pressure. GRK2 and GRK5 mRNA were evaluated in lymphocytes of black Americans via quantitative real-time PCR. GRK2 mRNA expression directly correlated with systolic blood pressure and norepinephrine levels. GRK2 was elevated >30% among those with systolic blood pressure > or =130 mm Hg. No significant correlation between GRK5 mRNA expression and blood pressure or catecholamines was observed. Diabetic status, age, sex, and body mass index were also compared with GRK2 expression using univariate and multivariate analyses. GRK2 protein expression was elevated 2-fold in subjects with higher blood pressure, and GRK activity was increased >40%. Our data suggest that GRK2, but not GRK5, is correlated with increasing blood pressure in black Americans. Understanding the receptors stimulated by increased neurohormonal activation may give insight into the pathophysiology of hypertension in this at-risk population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487588      PMCID: PMC2745090          DOI: 10.1161/HYPERTENSIONAHA.108.125955

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

Review 1.  Catecholamines, cardiac beta-adrenergic receptors, and heart failure.

Authors:  R J Lefkowitz; H A Rockman; W J Koch
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Implications of obesity for cardiovascular disease in blacks: the CARDIA and ARIC studies.

Authors:  A R Folsom; G L Burke; C L Byers; R G Hutchinson; G Heiss; J M Flack; D R Jacobs; B Caan
Journal:  Am J Clin Nutr       Date:  1991-06       Impact factor: 7.045

4.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

5.  Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.

Authors:  A H van den Meiracker; A J Man in't Veld; F Boomsma; D J Fischberg; P B Molinoff; M A Schalekamp
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

6.  Race, borderline hypertension, and hemodynamic responses to behavioral stress before and after beta-adrenergic blockade.

Authors:  K C Light; A Sherwood
Journal:  Health Psychol       Date:  1989       Impact factor: 4.267

Review 7.  The sympathetic nervous system: the muse of primary hypertension.

Authors:  V DeQuattro; M Feng
Journal:  J Hum Hypertens       Date:  2002-03       Impact factor: 3.012

Review 8.  Obesity, hypertension, and sympathetic nervous system activity.

Authors:  D B Corry; M L Tuck
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

9.  Effect of high blood pressure stress on vascular adrenergic responsiveness in the spontaneously hypertensive rat.

Authors:  E E Soltis; F P Field
Journal:  Clin Exp Hypertens A       Date:  1984

Review 10.  The renin-angiotensin system: renal actions and blood pressure regulation.

Authors:  J E Hall
Journal:  Compr Ther       Date:  1991-05
View more
  22 in total

Review 1.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

Review 2.  GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.

Authors:  Alessandro Cannavo; Walter J Koch
Journal:  Cell Signal       Date:  2017-01-07       Impact factor: 4.315

3.  GRK2 targeted knock-down results in spontaneous hypertension, and altered vascular GPCR signaling.

Authors:  Elena Tutunea-Fatan; Fabiana A Caetano; Robert Gros; Stephen S G Ferguson
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 4.  betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease.

Authors:  Henriette Brinks; Walter J Koch
Journal:  J Cardiovasc Transl Res       Date:  2010-07-10       Impact factor: 4.132

Review 5.  The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets.

Authors:  Petronila Penela; Cristina Murga; Catalina Ribas; Vanesa Lafarga; Federico Mayor
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 6.  Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.

Authors:  Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

7.  Increased circulating inflammatory endothelial cells in blacks with essential hypertension.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; John R Woollard; Sandra M Herrmann; Monika L Gloviczki; Ahmed Saad; Luis A Juncos; David A Calhoun; Andrew D Rule; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2013-06-24       Impact factor: 10.190

Review 8.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 9.  Taking the heart failure battle inside the cell: small molecule targeting of Gβγ subunits.

Authors:  Fadia A Kamal; Alan V Smrcka; Burns C Blaxall
Journal:  J Mol Cell Cardiol       Date:  2011-01-21       Impact factor: 5.000

10.  Improvement of vascular insulin sensitivity by downregulation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive rats.

Authors:  Wenjuan Xing; Youyou Li; Haifeng Zhang; Chunjuan Mi; Zuoxu Hou; Michael J Quon; Feng Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-02       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.